Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
Clinical trial NCT02813486 · UNKNOWN
Trial details
- NCT number
- NCT02813486
- Sponsor
- Green Cross Corporation
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2016-11-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.